| Stephanie Weiseman, | |
|
5197 Coventry Ln, Barboursville, VA 22923-1618 | |
| (703) 965-4750 | |
| Not Available |
| Full Name | Stephanie Weiseman |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapy |
| Experience | 20 Years |
| Location | 5197 Coventry Ln, Barboursville, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508132945 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 0119004142 (Virginia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Fox Rehabilitation Services Llc | 1355347410 | 258 |
News Archive
A multidisciplinary team from the Montreal Heart Institute (MHI) performed its first catheter implantation of a new prosthesis (Amptlazer(R) Cardiac Plug) closing the appendage of the left atrium of the heart, which will have the effect of preventing the formation of blood clots and avoiding open-heart surgery. This is excellent news for patients suffering from atrial fibrillation, the most common form of cardiac arrhythmia, affecting at least 5% of Canadians over the age of 70.
Researchers at Fox Chase Cancer Center uncovered a genetic pattern that may help predict how gastrointestinal stromal tumor (GIST) patients respond to the targeted therapy imatinib mesylate (Gleevec). Moreover, their findings point to genes that could be suppressed in order to make these tumors respond more readily to imatinib.
Kathleen Kalaf has been to hell and back in her long fight with systemic Candida. Today, thanks to a new Candida treatment that is more effective than even the most popular Candida remedies, Kalaf is finally free of the yeast overgrowth that stole eight years of her life - and she wants other Candida sufferers to know about Candida Force (http://www.candidaforce.com).
European drug regulations need changing to ensure they meet the needs of patients and doctors, argue experts in this week's British Medical Journal.
› Verified 7 days ago
| Provider Name | Fox Rehabilitation Services Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1609814755 PECOS PAC ID: 1355347410 Enrollment ID: O20091019000338 |
News Archive
A multidisciplinary team from the Montreal Heart Institute (MHI) performed its first catheter implantation of a new prosthesis (Amptlazer(R) Cardiac Plug) closing the appendage of the left atrium of the heart, which will have the effect of preventing the formation of blood clots and avoiding open-heart surgery. This is excellent news for patients suffering from atrial fibrillation, the most common form of cardiac arrhythmia, affecting at least 5% of Canadians over the age of 70.
Researchers at Fox Chase Cancer Center uncovered a genetic pattern that may help predict how gastrointestinal stromal tumor (GIST) patients respond to the targeted therapy imatinib mesylate (Gleevec). Moreover, their findings point to genes that could be suppressed in order to make these tumors respond more readily to imatinib.
Kathleen Kalaf has been to hell and back in her long fight with systemic Candida. Today, thanks to a new Candida treatment that is more effective than even the most popular Candida remedies, Kalaf is finally free of the yeast overgrowth that stole eight years of her life - and she wants other Candida sufferers to know about Candida Force (http://www.candidaforce.com).
European drug regulations need changing to ensure they meet the needs of patients and doctors, argue experts in this week's British Medical Journal.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Stephanie Weiseman, 5197 Coventry Ln, Barboursville, VA 22923-1618 Ph: () - | Stephanie Weiseman, 5197 Coventry Ln, Barboursville, VA 22923-1618 Ph: (703) 965-4750 |
News Archive
A multidisciplinary team from the Montreal Heart Institute (MHI) performed its first catheter implantation of a new prosthesis (Amptlazer(R) Cardiac Plug) closing the appendage of the left atrium of the heart, which will have the effect of preventing the formation of blood clots and avoiding open-heart surgery. This is excellent news for patients suffering from atrial fibrillation, the most common form of cardiac arrhythmia, affecting at least 5% of Canadians over the age of 70.
Researchers at Fox Chase Cancer Center uncovered a genetic pattern that may help predict how gastrointestinal stromal tumor (GIST) patients respond to the targeted therapy imatinib mesylate (Gleevec). Moreover, their findings point to genes that could be suppressed in order to make these tumors respond more readily to imatinib.
Kathleen Kalaf has been to hell and back in her long fight with systemic Candida. Today, thanks to a new Candida treatment that is more effective than even the most popular Candida remedies, Kalaf is finally free of the yeast overgrowth that stole eight years of her life - and she wants other Candida sufferers to know about Candida Force (http://www.candidaforce.com).
European drug regulations need changing to ensure they meet the needs of patients and doctors, argue experts in this week's British Medical Journal.
› Verified 7 days ago
Heather Coy, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2980 Burnley Station Rd, Barboursville, VA 22923 Phone: 256-221-8826 |